Here are four points:
1. Analysts have set a 12-month consensus target price of $19.67 for the stock.
2. EndoChoice has a 12-month low of $7.37 and a 12-month high of $19.69.
3. The firm has a 50-day moving average of $8.92 and a 200-day moving average of $13.40.
4. The stock’s market cap is $205.05 million.
More articles on GI/endoscopy:
Offering Cologuard increases colonoscopy at USMD Health System
Torax Medical’s continence restoration system receives FDA clearance, Advanced Endoscopy Devices contracts with Premier & more – 4 GI/endoscopy company key notes
GI physician leader to know: Dr. Christine Carter-Kent of Medical University of South Carolina
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
